Arkolith/Insider Trading/CHRS/Form 4

Lanfear Dennis M

President & CEO, DirectorCoherus BioSciences, Inc. (CHRS) · full profile →Form 4 · filed Jun 8, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$421K
Net Open-Market Flow
-$421K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 8, 2021Sell(S)31K$13.56$421K493K
Jun 8, 2021Option exercise(M)31K$0.42$13K524K
Jun 6, 2021Option exercise(M)300K$0.42$126K493K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 8, 2021Option exercise(M)31K—$00
Jun 6, 2021Option exercise(M)300K—$031K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-21-011842) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Coherus BioSciences, Inc.

Build

Ask your agent about CHRS insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001567619-21-011842"
Ask your agent
Use Arkolith to summarize insider buying and selling at Coherus BioSciences, Inc.
over the last 90 days and cite the filings.